No Picture
News

Amgen tops cost watchdog’s price gougers list based on ‘unfounded’ increases for Enbrel without meaningful data

In a top 10 ranking of the most egregious price gougers from 2019, Amgen’s Enbrel topped US cost watchdog ICER’s naughty list with “unfounded” markups that added as much as $403 million to the nation’s drug spend during that time. Price increases for s… […]

No Picture
News

A much-hyped CV drug failed, repeatedly. Now, investors are betting nearly $200M on one last PhIII bid

Just under a decade ago, Eli Lilly announced early results for a new drug that lowered bad cholesterol and raised good cholesterol. It was a “holy grail” result, as JAMA put it in a press release, offering a path for a pill that could curb cardiovascul… […]

No Picture
News

Global WholeHealth Partners, Corp (OTC: GWHP) Announces New Purchase Agreement From RyZac Health as Order Size Increases Over 3 Times

San Clemente, CA, Jan. 13, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Global WholeHealth Partners Corp, a multinational supplier of over 70+ with 56 products FDA approved and several approved for export only including Dengue, Ebola, Zika, Malaria a… […]